- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 207/16 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Patent holdings for IPC class C07D 207/16
Total number of patents in this class: 1279
10-year publication summary
|
98
|
84
|
106
|
113
|
104
|
72
|
78
|
62
|
78
|
125
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| ThermoLife International, LLC | 187 |
63 |
| F. Hoffmann-La Roche AG | 7784 |
25 |
| Givaudan SA | 1991 |
16 |
| Epics Therapeutics | 26 |
16 |
| Bristol-myers Squibb Company | 4751 |
15 |
| Pfizer Inc. | 3426 |
15 |
| Hoffmann-La Roche Inc. | 3876 |
14 |
| Omeros Corporation | 307 |
14 |
| Novartis AG | 10160 |
13 |
| President and Fellows of Harvard College | 6119 |
13 |
| Life Technologies Corporation | 3496 |
12 |
| Aichi Steel Corporation | 394 |
11 |
| Tokushima University | 250 |
11 |
| Xwpharma Ltd. | 65 |
11 |
| The Regents of the University of California | 20987 |
10 |
| Biogen MA Inc. | 947 |
10 |
| Cytokinetics, Inc. | 251 |
9 |
| Abbvie Inc. | 1810 |
8 |
| Astellas Pharma Inc. | 1043 |
8 |
| Enanta Pharmaceuticals, Inc. | 427 |
8 |
| Other owners | 977 |